Mondo Visione Worldwide Financial Markets Intelligence
Track all markets on TradingView

FTSE Mondo Visione Exchanges Index:

BT_Radianz_468x60_Jul23

NYSE Euronext Announces Trading Volumes For January 2009

Date 09/02/2009

NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for January 20091.

Cash Trading

U.S. cash products handled average daily volume (“ADV”) decreased 8.9% to 3.5 billion shares2.

  • Total NYSE-listed (Tape A) consolidated volume increased 8.3% to 5.4 billion shares.
  • NYSE-listed matched volume (Tape A) decreased 13.8% to 2.3 billion shares.
  • Tape A matched market share was 42.3%, compared to 43.4% in December 2008 and 58.4% in January 2008.
  • Designated Market Maker (DMM) participation in January 2009 was 8.4%, the highest level of participation since February 2006, and up from 7% in December 2008. The increased level of participation was driven in part by the introduction of the NYSE’s new market model in October 2008.
  • Total NYSE Arca and NYSE Amex-listed consolidated volume (Tape B) increased 60.4% to 2.0 billion shares.
  • NYSE’s matched volume of Tape B increased 38.4% to 540 million shares.
  • Total Nasdaq-listed (Tape C) consolidated volume decreased 23.8% to 2.1 billion shares.
  • NYSE’s matched volume of Tape C decreased 26.6% to 324 million shares.
  • Tape C matched market share was relatively stable at 15.8%, compared to 15.6% in December 2008 and 16.4% in January 2008.
  • Exchange-traded funds matched volume (included in the trading volume numbers above) increased 24.8% to 535 million shares.

European cash products ADV decreased 29.5% to 1.3 million transactions2 from 1.9 million transactions in January 2008, which was the second highest monthly ADV in 2008.

  • European cash trading activity qualifying for Pack Epsilon pricing represented 35% of total transactions executed.

Derivatives Trading

European derivatives products ADV was 3.8 million futures and options contracts, a decrease of 18.4% from January 2008, primarily driven by a decline in interest rate trading volume.

  • Total interest rate products ADV decreased 32.1% to 2.0 million contracts from 2.9 million contracts in January 2008, which was the highest monthly ADV ever for interest rate products.
  • Total equity products (including Bclear) ADV increased 5.6% to 1.8 million contracts. Bclear, NYSE Liffe's trade administration and clearing service, processed 779 thousand contracts per day, an increase of 98.2%.

U.S. equity options ADV decreased 13.7% to 2.1 million contracts. Total consolidated options ADV declined 23.5% to 12.0 million contracts. NYSE Euronext’s U.S. options exchanges (NYSE Arca and NYSE Amex) accounted for 17.4% of the total consolidated equity options trading in January, up from 15.4% in January 2008.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is the world’s leading, most liquid and diverse exchange group. It offers a broad and growing array of financial products and services in cash equities, futures, options, exchange-traded products, bonds, market data, and commercial technology solutions, all designed to meet the evolving needs of issuers, investors and financial institutions. Spanning multiple asset classes and six countries, NYSE Euronext’s exchanges include the New York Stock Exchange, Liffe, Euronext and NYSE Arca. With more than 6,500 listed issues, more than any other exchange group, trading on NYSE Euronext’s equity markets represents more than one-third of the world's cash equities volume. NYSE Euronext also manages the leading European derivatives exchange by value of trading. NYSE Euronext is part of the S&P 500 index and the only exchange operator in the S&P 100 index. For more information, please visit www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2007 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on May 15, 2008 under No. R. 08-054), 2007 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All comparisons versus January 2008 unless otherwise stated.

2 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary - Cash Products

             
Average Daily Volume Total Volume Total Volume
(Unaudited) Jan-09 Jan-08 % Chg Jan-09 Jan-08 % Chg YTD 2009

% Chg vs.
YTD 2008

 
Number of Trading Days - European Markets 21 22 21 22 21
Number of Trading Days - U.S. Markets 20 21 20 21 20
 
European Cash Products (trades in thousands) 1,329 1,886 -29.5 % 27,918 41,501 -32.7 % 27,918 -32.7 %
 
Equities 1,264 1,821 -30.6 % 26,542 40,052 -33.7 % 26,542 -33.7 %
Exchange-Traded Funds 13 11 16.2 % 275 248 10.9 % 275 10.9 %
Structured Products 47 48 -2.1 % 996 1,065 -6.5 % 996 -6.5 %
Bonds 5 6 -18.8 % 106 137 -22.5 % 106 -22.5 %
 
U.S. Cash Products (shares in millions) 2 3,540 3,885 -8.9 % 70,790 81,580 -13.2 % 70,790 -13.2 %
 
NYSE Listed (Tape A) Issues 1
 
NYSE Group Handled Volume 2 2,520 2,894 -12.9 % 50,390 60,780 -17.1 % 50,390 -17.1 %
NYSE Group Matched Volume 3 2,271 2,634 -13.8 % 45,430 55,311 -17.9 % 45,430 -17.9 %
NYSE Group TRF Volume 4 9 208 -95.6 % 184 4,359 -95.8 % 184 -95.8 %
Total NYSE Listed Consolidated Volume 5,370 4,959 8.3 % 107,394 104,149 3.1 % 107,394 3.1 %
 
NYSE Group Share of Total Consolidated Volume
Handled Volume 2 46.9 % 58.4 % -11.5 % 46.9 % 58.4 % -11.5 % 46.9 % -11.5 %
Matched Volume 3 42.3 % 53.1 % -10.8 % 42.3 % 53.1 % -10.8 % 42.3 % -10.8 %
TRF Volume 4 0.2 % 4.2 % -4.0 % 0.2 % 4.2 % -4.0 % 0.2 % -4.0 %
 
NYSE Arca & Alternext US (Tape B) Listed Issues
 
NYSE Group Handled Volume 2 622 454 37.0 % 12,445 9,540 30.4 % 12,445 30.4 %
NYSE Group Matched Volume 3 540 390 38.4 % 10,802 8,197 31.8 % 10,802 31.8 %
NYSE Group TRF Volume 4 1 85 -98.8 % 21 1,788 -98.8 % 21 -98.8 %
Total NYSE Arca & Amex Listed Consolidated Volume 2,037 1,269 60.4 % 40,736 26,658 52.8 % 40,736 52.8 %
 
NYSE Group Share of Total Consolidated Volume
Handled Volume 2 30.6 % 35.8 % -5.2 % 30.6 % 35.8 % -5.2 % 30.6 % -5.2 %
Matched Volume 3 26.5 % 30.7 % -4.2 % 26.5 % 30.7 % -4.2 % 26.5 % -4.2 %
TRF Volume 4 0.1 % 6.7 % -6.6 % 0.1 % 6.7 % -6.6 % 0.1 % -6.6 %
 
Nasdaq Listed (Tape C) Issues
 
NYSE Group Handled Volume 2 398 536 -25.8 % 7,955 11,260 -29.3 % 7,955 -29.3 %
NYSE Group Matched Volume 3 324 441 -26.6 % 6,474 9,257 -30.1 % 6,474 -30.1 %
NYSE Group TRF Volume 4 7 203 -96.4 % 148 4,257 -96.5 % 148 -96.5 %
Total Nasdaq Listed Consolidated Volume 2,051 2,691 -23.8 % 41,011 56,502 -27.4 % 41,011 -27.4 %
 
NYSE Group Share of Total Consolidated Volume
Handled Volume 2 19.4 % 19.9 % -0.5 % 19.4 % 19.9 % -0.5 % 19.4 % -0.5 %
Matched Volume 3 15.8 % 16.4 % -0.6 % 15.8 % 16.4 % -0.6 % 15.8 % -0.6 %
TRF Volume 4 0.4 % 7.5 % -7.1 % 0.4 % 7.5 % -7.1 % 0.4 % -7.1 %
 
Exchange-Traded Funds 1,5
 
NYSE Group Handled Volume 2 617 497 24.2 % 12,339 10,430 18.3 % 12,339 18.3 %
NYSE Group Matched Volume 3 535 429 24.8 % 10,708 9,010 18.8 % 10,708 18.8 %
NYSE Group TRF Volume 4 1 104 -99.3 % 15 2,178 -99.3 % 15 -99.3 %
Total ETF Consolidated Volume 2,060 1,391 48.1 % 41,195 29,215 41.0 % 41,195 41.0 %
 
NYSE Group Share of Total Consolidated Volume
Handled Volume 2 30.0 % 35.7 % -5.7 % 30.0 % 35.7 % -5.7 % 30.0 % -5.8 %
Matched Volume 3 26.0 % 30.8 % -4.8 % 26.0 % 30.8 % -4.8 % 26.0 % -4.8 %
TRF Volume 4 0.0 % 7.5 % -7.5 % 0.0 % 7.5 % -7.5 % 0.0 % -7.5 %

NYSE Euronext

Monthly Volume Summary - Derivatives Products

               
Average Daily Volume Total Volume Total Volume
(Unaudited; contracts in thousands) Jan-09 Jan-08 % Chg Jan-09 Jan-08 % Chg YTD 2009

% Chg vs.
YTD 2008

 
Number of Trading Days - European Markets 21 22 21 22 21
Number of Trading Days - U.S. Markets 20 21 20 21 20
 
European Derivatives Products 3,826 4,691 -18.4 % 80,349 103,192 -22.1 % 80,349 -22.1 %
 
Total Interest Rate Products 6 1,989 2,927 -32.1 % 41,760 64,399 -35.2 % 41,760 -35.2 %
 
Short Term Interest Rate Products 1,911 2,829 -32.5 % 40,127 62,235 -35.5 % 40,127 -35.5 %
Medium and Long Term Interest Rate Products 78 98 -20.9 % 1,633 2,164 -24.5 % 1,633 -24.5 %
 
Total Equity Products 7 1,793 1,698 5.6 % 37,655 37,357 0.8 % 37,655 0.8 %
 
Individual Equity Products 1,196 894 33.8 % 25,124 19,673 27.7 % 25,124 27.7 %
Equity Index Products 597 804 -25.8 % 12,532 17,684 -29.1 % 12,532 -29.1 %
 
of which Bclear 779 393 98.2 % 16,363 8,647 89.2 % 16,363 89.2 %
Individual Equity Products 650 268 142.6 % 13,653 5,895 131.6 % 13,653 131.6 %
Equity Index Products 129 125 3.2 % 2,711 2,752 -1.5 % 2,711 -1.5 %
 
Commodity Products 44 65 -31.8 % 934 1,436 -34.9 % 934 -34.9 %
 
U.S. Derivatives Products
 
U.S. Derivatives Products - Equity Options 8
 
NYSE Group Options Contracts 2,086 2,418 -13.7 % 41,725 50,786 -17.8 % 41,725 -17.8 %
Total Consolidated Options Contracts 11,974 15,656 -23.5 % 239,490 328,781 -27.2 % 239,490 -27.2 %
 
NYSE Group Share of Total 17.4 % 15.4 % 17.4 % 15.4 % 17.4 % 2.0 %
1   Includes all volume executed in NYSE Group crossing sessions.
2 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
3 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
4 Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility (TRF).
5 Data included in previously identified categories.
6 Data includes currency products.

7

Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives.
8 Includes trading in U.S. equity options contracts, not equity-index options.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
US Equities data has been updated for Amex integration for October 2008 forward.
Confinity_sky1-min.gif BT_Radianz_120x600_Jul23.jpg